4G Clinical was featured in a white paper by First Analysis entitled, "eClinical Solutions: Streamlining the introduction of new drugs and medical technology." This comprehensive paper covers the full spectrum of eclinical solutions including RTSM, EDC, CTMS, eCOA, eTMF among others. Below is an excerpt from the paper regarding 4G Clinical.
"One start-up using innovative technology to enhance RTSM is 4G Clinical. Through the use of natural language processing (NLP), 4G clinical has built a configurable and agile RTSM platform called Prancer that reduces traditional system build from 6-8 weeks to under four weeks."
Amy Ripston, 4G Clinical Vice President of Marketing, has over 20 years of B2B experience, of which she spent 9 years in the bio/pharmaceutical industry. Amy has a knack for identifying market trends, synthesizing content, engaging thought leaders, and connecting businesses with innovative solutions.